Why Stock-Pickers Could Lead The Coming Decade

The S&P 500's multi-decade high valuation is largely attributed to the "Magnificent Seven," with the equal-weighted S&P 500 suggesting the broader market is not broadly overvalued. The analysis argues that while AI benefits are currently concentrated in a few intermediaries, future productivity gains will spread across the economy, creating opportunities in undervalued stocks and the equal-weighted index (RSP). Consequently, a strategy favoring RSP or targeted stock-picking in sectors like healthcare is recommended over the concentrated SPX, acknowledging risks such as continued mega-cap outperformance or delayed AI impact.

Analysis

The current market rally, fueled by AI optimism, has pushed the S&P 500 (SPX) to multi-decade high valuations across metrics like P/E, P/B, and EV/EBITDA, a level historically preceding lower long-term returns. However, this overvaluation is highly concentrated within a few mega-cap stocks, most notably the "Magnificent Seven." The equal-weighted S&P 500 (RSP) trades only slightly above its historical average P/E of 17x, indicating that the broader market is not experiencing the same valuation extremity. The analysis posits that while current market pricing favors AI intermediaries like Nvidia (NVDA), which is showing signs of slowing data center revenue growth at 5% quarter-over-quarter, the long-term productivity gains from AI will diffuse across the entire economy. This suggests opportunities exist in undervalued areas. For instance, the healthcare sector is trading near historical lows relative to the market, with companies like UnitedHealth (UNH) and Elevance Health (ELV) identified as attractive due to solid growth and potential for AI-driven cost reductions. Despite the compelling case for diversification through RSP or stock-picking, risks include continued mega-cap outperformance, uneven impacts from macroeconomic factors like inflation (cited as 2.9% YoY in August 2025), and potential delays in the materialization of widespread AI benefits.

Key Decisions for Investors

• Investors should consider shifting exposure from the market-cap-weighted SPX, which is rated a 'Hold', towards the equal-weighted RSP or the QQQ, both rated 'Buy', to mitigate concentration risk and access a more reasonably valued segment of the U.S. market.
• A targeted stock-picking strategy focused on undervalued sectors with latent AI efficiency potential, such as healthcare stocks like UNH and ELV, may offer a superior risk-to-reward profile than passive index investing.
• Monitor key valuation and growth metrics for mega-cap tech leaders, as slowing growth like NVDA's 5% QoQ data center revenue increase could signal that elevated expectations are becoming detached from reality, posing a risk to the concentrated SPX.
• Remain cautious of macroeconomic risks, as a rise in interest rates to combat inflation could compress valuations and disproportionately affect the performance of diversified or value-oriented strategies relative to the concentrated index.